-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KHBmfFoomhSh7Vxukretbhask/RBJtz6JI17oTizFKu2E6ZPl+MfzpjGRSV09a1I 26S4l0p8Xp05Gd+oY5tUVA== 0000950130-97-005618.txt : 19971219 0000950130-97-005618.hdr.sgml : 19971219 ACCESSION NUMBER: 0000950130-97-005618 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19971217 ITEM INFORMATION: FILED AS OF DATE: 19971218 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-10432 FILM NUMBER: 97740274 BUSINESS ADDRESS: STREET 1: 4 INDUSTRIAL WAY WEST STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07755 BUSINESS PHONE: 7323891182 MAIL ADDRESS: STREET 1: 4 INDUSTRIAL WAY WEST STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07755 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 1997 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) New Jersey 1-1-432 22-2429994 - --------------------- --------------- -------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive officers, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Former name or former address, if changed from last report) Item 5. Other Events ------------ Roberts Pharmaceutical Corporation announced today that they have entered into a product transaction agreement with Searle. Roberts will receive exclusive North American distribution rights with a future right to purchase Slow-Mag(R), a uniquely formulated, slow-release, highly soluble and readily absorbed form of magnesium which is essential in maintaining the heart, kidneys, muscles and bones. Slow-Mag(R) is an ethical, over-the-counter (OTC) product that is generally marketed directly to physicians for use in those patients requiring magnesium supplementation. Magnesium deficiency can be associated with cardiac arrhythmia and congestive heart failure. Roberts is actively engaged in the development and marketing of cardiovascular agents and considers Slow-Mag(R) to be a strong fit with its interests in the cardiovascular area. Searle will receive a combination of cash installment payments, totaling about $15 million over more than two years, and rights to the oral contraceptive Norethin(TM), a product outside the principal area of therapeutic focus for Roberts. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: December 18, 1997 By: /s/ Anthony A. Rascio ----------------------------- Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----